We are live on ! Find out more
AYTU icon

AYTU BioPharma
AYTU

14 hedge funds and large institutions have $765K invested in AYTU BioPharma in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

40% more funds holding

Funds holding: 10 → 14 (+4)

0% less ownership

Funds ownership: 0% → 0% (-0%)

67% less capital invested

Capital invested by funds: $2.35M → $765K (-$1.58M)

Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$314K
2
SM
Sabby Management
Florida
+$295K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$145K
4
Citadel Advisors
Citadel Advisors
Florida
+$91.8K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$71.7K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$956K
2
HCM
Highbridge Capital Management
New York
-$681K
3
MA
MCF Advisors
Kentucky
-$227K
4
CCM
Courage Capital Management
Tennessee
-$103K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$197K +$314K +188 New
SM
2
Sabby Management
Florida
$186K +$295K +177 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$95K +$145K +87 +2,900%
Citadel Advisors
4
Citadel Advisors
Florida
$81K +$91.8K +55 +250%
KJHP
5
K.J. Harrison & Partners
Ontario, Canada
$53K – – –
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$48K +$71.7K +43 +1,433%
CCM
7
Courage Capital Management
Tennessee
$39K -$103K -62 -62%
UBS Group
8
UBS Group
Switzerland
$13K +$20K +12 +1,200%
TSS
9
Two Sigma Securities
New York
$13K +$21.7K +13 New
NMC
10
NEA Management Company
Maryland
$12K – – –
VF
11
Virtu Financial
New York
$10K +$15K +9 New
FMC
12
First Merchants Corp
Indiana
$8K +$13.3K +8 New
RJFSA
13
Raymond James Financial Services Advisors
Florida
$7K +$10K +6 New
Invesco
14
Invesco
Georgia
$3K +$5K +3 New
AC
15
Armistice Capital
New York
– -$956K -375 Closed
HCM
16
Highbridge Capital Management
New York
– -$681K -267 Closed
MA
17
MCF Advisors
Kentucky
– -$227K -89 Closed

AYTU Hedge Fund Activity: Q2 2018 in Review

14 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q2 2018, worth a combined $765K — down 67% from $2.35M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AYTU positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $314K. The largest seller was Armistice Capital, exiting entirely with an estimated $956K sold.

  • 14 institutional investors held AYTU BioPharma (AYTU) as of Q2 2018, up from 10 in Q1 2018.
  • Funds reported $765K of AYTU BioPharma stock for Q2 2018, down 67% quarter-over-quarter.
  • 7 funds opened new AYTU BioPharma positions in Q2 2018 and 3 closed out, a net change of +4 holders.
  • The largest AYTU BioPharma buyer in Q2 2018 was Vanguard Group, an estimated $314K added.
  • The largest AYTU BioPharma seller in Q2 2018 was Armistice Capital, an estimated $956K sold.

Based on aggregated 13F filings for Q2 2018.